Drugmakers may push to boost U.S. government spending on prescription drugs even as the U.S. Congress seeks to reduce health-care spending, according to internal documents from the industry’s top lobbying group.
Representative Zack Space , a two- term Democrat running for re-election in Ohio, faces an online campaign urging voters to boycott his candidacy. The anti- incumbent pitch isn’t from Republicans or Tea Party activists.
Gina Raimondo was running a Rhode Island venture-capital firm in Providence when the mother of two read with alarm that a growing fiscal crisis might force cutbacks in library hours and bus service in 2009.
Drugmakers led by Pfizer Inc. agreed to run a “very significant public campaign” bankrolling political support for the 2010 health-care law, including TV ads, while the Obama administration promised to block provisions opposed by drugmakers, documents released by Republicans show.
A Republican demand that an increase in the U.S. debt limit be matched by spending reductions may do more than force painful cuts. It could mean another vote on the borrowing cap at the height of the 2012 election campaign.
A dispute has erupted within the pharmaceutical industry over how to respond to a government proposal in South Africa to allow local manufacturers to copy brand-name drugs and sell them in the country at a lower cost.